Physician profile
David M Lee
NPI 1801850201
$8,441.73
in general payments reported to CMS, 2019-2025
23 companies · $8.25 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $500 · 2020: $3,756 · 2021: $3,246 · 2022: $378 · 2023: $343 · 2024: $211 · 2025: $8.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $6,466.83 | 2020-2023 | Apretude |
| Depuy Synthes Sales INC. | $255.48 | 2019 | |
| Lumendi LLC | $234.98 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $222.82 | 2019-2023 | Delstrigo, Dificid, Pifeltro |
| Gilead Sciences, INC. | $219.47 | 2021-2022 | |
| Conmed Corporation | $189.38 | 2024 | Conmed Eus |
| Emd Serono, INC. | $124.08 | 2022-2023 | Serostim |
| Boston Scientific Corporation | $111.11 | 2023 | Exalt Model D |
| Allergan, INC. | $97.92 | 2019 | |
| Ambu INC. | $91.46 | 2021 | |
| Hologic Sales and Service, LLC | $73.85 | 2023 | Aptima |
| Antares Pharma, INC. | $70.11 | 2020-2021 | |
| Novo Nordisk INC | $41.74 | 2019-2023 | Ozempic, Rybelsus |
| Abbvie INC. | $38.57 | 2021 | |
| Medtronic, INC. | $30.17 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Erbe USA INC | $30.00 | 2020 | |
| Vbi Vaccine (Delaware) INC. | $29.24 | 2022 | |
| Janssen Pharmaceuticals, INC | $28.48 | 2022 | |
| Bayer Healthcare LLC | $21.58 | 2024 | |
| Abbott Laboratories | $19.93 | 2021 | |
| Janssen Biotech, INC. | $16.71 | 2021 | |
| Fresenius Kabi USA, LLC | $15.16 | 2021 | |
| Glaxosmithkline, LLC. | $12.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.